会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • QUATERNARY AMINO-FUNCTIONAL CHALCONES
    • 第四季度AMINO-FUNCTIONAL CHALCONES
    • WO2005042467A1
    • 2005-05-12
    • PCT/DK2004/000746
    • 2004-10-28
    • LICA PHARMACEUTICALS A/SNIELSEN, Simon, Feldbæk
    • NIELSEN, Simon, Feldbæk
    • C07C225/22
    • C07D295/112C07C217/22C07C225/16C07C225/22
    • The present invention provides novel quaternary amino-functional chalcone derivatives and analogues exhibiting interesting antibacterial activity. The compounds have the general formula (Y 1 ) m -Ar 1 (X 1 )-C(=O)Var 2 (X 2 )-(Y 2 ) p (I), wherein V designates -CH 2 -CH 2 -, -CH=CH-or -C=C; Ar 1 and Ar 2 independently are aryl and heteroary.; m=0, 2, p=0, 1, 2, m+p>0; each Y 1 and Y 2 independently is -Z-N + (R 1 )(R 2 )R 4 Q - (A); -NR 3 -Z-N + (R 1 )(R 2 )R 4 Q - (B), or O-Z-N + (R 1 )(R 2 )R 4 Q - (C), R 1 , R 2 , R 3 , R 4 , X 1 , X 2 are substituents, and Q - is an anion. The present invention also relates to the compounds for sue as pharmaceutically active agents, in particular against bacterial infections (such as Gram-negative and Gram-positive bacteria, including antibiotic-sensitive or resistant strains), and in the medical treatment of bacterial infections in mammals.
    • 本发明提供了具有令人感兴趣的抗菌活性的新型季氨基功能查耳酮衍生物和类似物。 这些化合物具有通式(Y 1)m -Ar 1(X 1)-C(= O)Var 2(X 2) - (Y 2)p(I ),其中V表示-CH 2 -CH 2 - , - CH = CH-或-C = C; Ar 1和Ar 2独立地是芳基和杂芳基。 m = 0,2,p = 0,1,2,m + p> 0; 每个Y 1和Y 2独立地是-Z-N +(R 1)(R 2)R 4 Q - (A); (R 1)(R 2)R 4(B)或OZN +(R 1)(R 2) )R 4(C),R 1,R 2,R 3,R 4,X 1,X 2均为取代基, 是阴离子。 本发明还涉及作为药物活性剂的药物,特别是针对细菌感染(例如革兰氏阴性和革兰氏阳性菌,包括抗生素敏感或抗性菌株)的化合物,以及在细菌感染的治疗中 哺乳动物。
    • 9. 发明申请
    • SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS
    • 替代的乙草胺作为PDE4抑制剂有用
    • WO2008077404A1
    • 2008-07-03
    • PCT/DK2007/000564
    • 2007-12-21
    • LEO PHARMA A/SFELDING, JakobNIELSEN, Simon, Feldbæk
    • FELDING, JakobNIELSEN, Simon, Feldbæk
    • C07D213/61C07D413/12C07D417/12A61K31/44A61K31/4427A61P25/00A61P29/00A61P31/00A61P35/00
    • C07D213/61C07D413/12C07D417/12
    • The present invention relates to a compound according to formula: (I); wherein X 1 , X 2 , X 3 , X 4 and X 5 independently of each other represent -CH- or N; or X 3 , X 4 and X 5 independently of each other represent -CH- or N, and Xi and X 2 independently of each other represent C and form part of an additional 6- membered aromatic ring; R 1 represents hydrogen, alkyl, alke nyl, alkynyl, haloalkyl, hydroxyalkyl, or alkylcarbonyl, all of which are optionally substituted; R 2 and R 3 independently represent hydrogen, -CH 2 -C(O)NR-R', alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, haloalkyl, hydroxyalkyl, heterocycloalkenyl, alkylaryl, alkylalkoxycarbonyl, alkylcarbonyloxy, or alkoxyalkyl, all of which are optionally substituted; R 11 represents hydrogen, halogen, cyano, amino, alkoxy or alkylamino, X 1 -X 5 represent -CH- or N, including N-oxides, enantiomers and diastereomers; and pharmaceutically acceptable salts, hyd rates, or solvates thereof. The invention relates further to processes for the preparation of said compounds, to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.
    • 本发明涉及式(I)化合物: 其中X 1,X 2,X 3,X 4和X 5, 彼此独立地表示-CH-或N; 或X 3,X 4和X 5各自独立地表示-CH-或N,且X 1和X 2' 彼此独立地表示C并形成额外的6-元芳环的一部分; R 1表示氢,烷基,芳基,炔基,卤代烷基,羟基烷基或烷基羰基,它们均为任选取代的; R 2和R 3独立地表示氢,-CH 2 -C(O)NR-R',烷基,环烷基,烯基,环烯基 ,炔基,卤代烷基,羟基烷基,杂环烯基,烷基芳基,烷基烷氧基羰基,烷基羰基氧基或烷氧基烷基,它们均为任选取代的; R 11表示氢,卤素,氰基,氨基,烷氧基或烷基氨基,X 1 -X 5表示-CH-或N,包括N 氧化物,对映异构体和非对映异构体; 及其药学上可接受的盐,水合速率或溶剂化物。 本发明进一步涉及制备所述化合物,所述化合物用于治疗的方法,包含所述化合物的药物组合物,治疗疾病的方法。 所述化合物的皮肤病,以及所述化合物在制备药物中的用途。